Live Breaking News & Updates on Mark Kinarney

Stay updated with breaking news from Mark kinarney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary ....

United States , New Jersey , Tim Bateman , Debbie Leven , Francois Tranquart , Mark Kinarney , Centers For Disease , Global Head Of Clinical Development , Corporate Communications , Lantheus Holdings Inc , American Society Of Nuclear Cardiology , Ge Healthcare , Coronary Artery Disease , Perfusion Imaging , Molecular Imaging , American Society , Nuclear Cardiology , Positron Emission Tomography , Single Photon Emission Computed Tomography , Myocardial Perfusion Imaging , Open Label Study , Cardiovascular Radiologic Imaging Program , Saint Luke , Global Head , Clinical Development , Pharmaceutical Diagnostics ,

Lantheus to Present at the Wells Fargo Healthcare Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

New Jersey , United States , North Billerica , Bob Marshall , Paul Blanchfield , Mark Kinarney , Corporate Communications , Lantheus Holdings Inc , Chief Financial Officer , Chief Operating Officer , Wells Fargo Healthcare Conference , Investor Relations , Globe Newswire ,

Lantheus Holdings, Inc. (LNTH) CEO Mary Heino on Q2 2022 Results - Earnings Call Transcript

Lantheus Holdings, Inc. (NASDAQ:NASDAQ:LNTH) Q2 2022 Earnings Conference Call Aug 4, 2022 8:08 AM Company Participants Mark Kinarney - Senior Director, Investor Relations Mary Heino -. ....

New York , United States , District Of Columbia , West Virginia , Radiopharm Theranostics , Richard Newitter , Los Angeles , Mary Anne , Robert Marshall , Bob Marshall , Nicholas Nickols , Mary Anne Heino , E David Crawford , Roanna Ruiz , Mark Kinarney , Zachary Weiner , Mary Heino , Larry Solow , Zach Weiner , Paul Blanchfield , Anthony Petrone , Company Participants , American Urological Association , Exchange Commission Under Form , University Of California San Diego , Truist Company ,

Lantheus Hosts Inaugural Investor Day

Lantheus Outlines Sustainable and Profitable Growth Strategy; Introduces Long-Term Financial TargetsNORTH BILLERICA, M. ....

New Jersey , United States , North Billerica , Mary Anne Heino , Mark Kinarney , Bausch Health Companies Inc , Exchange Commission , Lantheus Medical Imaging Inc , Progenics Pharmaceuticals Inc , Corporate Communications , Securities Exchange , Lantheus Holdings Inc , Lantheus Outlines Sustainable , Profitable Growth Strategy , Introduces Long Term Financial , Inaugural Investor Day , Nasdaq Marketsite , Lantheus Holdings , Lantheus Medical Imaging , Progenics Pharmaceuticals , Find Fight , Perflutren Lipid Microsphere , Injectable Suspension , Bausch Health Companies , Private Securities Litigation Reform Act , Securities Act ,

Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological Association (AUA) Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , New Jersey , North Billerica , Nicholasg Nickols , Mark Kinarney , Bausch Health Companies Inc , Progenics Pharmaceuticals Inc , Exchange Commission , Lantheus Medical Imaging Inc , Corporate Communications , Securities Exchange , Lantheus Holdings Inc , American Cancer Society , Associate Professor , Radiation Oncology , Jean Claude Provost , Interim Chief Medical Officer , Lantheus Holdings , Lantheus Medical Imaging , Progenics Pharmaceuticals , Find Fight , Perflutren Lipid Microsphere , Injectable Suspension , Bausch Health Companies , Cautionary Statements , Private Securities Litigation Reform Act ,